KV Kumar, head of the Indian American International Chamber of Commerce, gives an account of the bilateral trade relations between India and the US and candidly speaks about the opportunities for Indian generic companies in the world’s largest pharmaceutical market. He addresses the need for supply chain diversification in light of COVID-19 and the continued importance for collaboration between the two countries.
What India offers is a focus on the rapidly expanding lower middle class with high quality, low-cost goods and services - a segment not typically addressed by US businesses
